FDA Warns of Fracture Risk with Diabetes Drug Canagliflozin (FREE)

By Kelly Young Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS The type 2 diabetes drug canagliflozin will carry a stronger label warning about the increased risk …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news